| scholarly article | Q13442814 |
| P2093 | author name string | Cheng-Har Yip | |
| Soo-Hwang Teo | |||
| Nur Aishah Taib | |||
| Chin-Vern Song | |||
| P2860 | cites work | Immediate versus delayed reconstruction following surgery for breast cancer | Q24235555 |
| Prophylactic mastectomy for the prevention of breast cancer | Q24236609 | ||
| Contralateral prophylactic mastectomy: current perspectives | Q26744320 | ||
| Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers | Q27003935 | ||
| Hereditary breast cancer. Identifying and managing BRCA1 and BRCA2 carriers. | Q33964990 | ||
| Prophylactic surgery in hereditary breast/ovarian cancer syndrome. | Q35187106 | ||
| Contralateral prophylactic mastectomy after unilateral breast cancer: a systematic review and meta-analysis | Q35192288 | ||
| BRCA mutation testing in determining breast cancer therapy | Q35619225 | ||
| Genetics of breast cancer: a topic in evolution | Q35775223 | ||
| Quality of life among patients after bilateral prophylactic mastectomy: a systematic review of patient-reported outcomes | Q35844333 | ||
| Utilization of screening and preventive surgery among unaffected carriers of a BRCA1 or BRCA2 gene mutation | Q35983873 | ||
| Gene-panel sequencing and the prediction of breast-cancer risk | Q36175072 | ||
| Risk-Reducing Strategies for Ovarian Cancer in BRCA Mutation Carriers: A Balancing Act. | Q36313479 | ||
| Extent of primary breast cancer surgery: standards and individualized concepts | Q36457859 | ||
| Role of Breast Surgery in BRCA Mutation Carriers | Q36457900 | ||
| Radiotherapy in the treatment of hereditary breast cancer | Q37816659 | ||
| Surgical management of breast cancer in BRCA-mutation carriers: a systematic review and meta-analysis | Q38190905 | ||
| Oestrogen receptor status, treatment and breast cancer prognosis in Icelandic BRCA2 mutation carriers | Q38378750 | ||
| BRCA mutation in ovarian cancer: testing, implications and treatment considerations | Q38644661 | ||
| Breast cancer treatment in mutation carriers: surgical treatment | Q38715493 | ||
| Effectiveness of Prophylactic Surgeries in BRCA1 or BRCA2 Mutation Carriers: A Meta-analysis and Systematic Review | Q38775675 | ||
| Clinical implications of germline mutations in breast cancer: TP53. | Q47607437 | ||
| Prophylactic Surgery: For Whom, When and How? | Q49885181 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | literature review | Q2412849 |
| P304 | page(s) | 863 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | Ecancermedicalscience | Q27722239 |
| P1476 | title | Surgery for , TP53 and PALB2: a literature review | |
| P478 | volume | 12 |
| Q89896922 | Analysis of Heterozygous BRCA1 5382ins Founder Mutation in a Cohort of Egyptian Breast Cancer Female Patients Using Pyrosequencing Technique |
| Q90319066 | Factors influencing the time to surgery after neoadjuvant chemotherapy in breast cancer patients |
| Q92382544 | Identification of a four-long non-coding RNA signature in predicting breast cancer survival |
Search more.